 | • レポートコード：QYR2104Z4150 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、96ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、夜間頻尿のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他）、用途別市場規模（病院薬局、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・夜間頻尿の市場動向 ・企業の競争状況、市場シェア ・夜間頻尿の種類別市場規模（抗コリン薬、デスモプレシン、抗生物質、鎮痙薬、その他） ・夜間頻尿の用途別市場規模（病院薬局、ドラッグストア、オンライン薬局） ・夜間頻尿の北米市場規模2016-2027（アメリカ、カナダ） ・夜間頻尿のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・夜間頻尿のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・夜間頻尿の中南米市場規模2016-2027（メキシコ、ブラジル） ・夜間頻尿の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Allergan、Urigen Pharmaceuticals、Ferring Pharmaceuticals、Glenmark Pharmaceuticals、Teva Pharmaceutical Industries、AA Pharma、Avadel Pharmaceuticals） ・結論 |
Nocturia, also called nycturia (Greek νυκτουρία), is defined by the International Continence Society (ICS) as “the complaint that the individual has to wake at night one or more times for voiding (i.e. to urinate).” Its causes are varied and, in many patients, difficult to discern.
Antispasmodic Drug Type Segment to Exhibit a High Growth Rate During the Forecast Period.
Market Analysis and Insights: Global Nocturia Market
The global Nocturia market size is projected to reach US$ 3180.5 million by 2026, from US$ 2039.4 million in 2019, at a CAGR of 6.5% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nocturia market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nocturia market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nocturia market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nocturia market.
Global Nocturia Scope and Market Size
Nocturia market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nocturia market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Anticholinergic Drugs
Desmopressin
Antibiotics
Antispasmodic
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Allergan
Urigen Pharmaceuticals
Ferring Pharmaceuticals
Glenmark Pharmaceuticals
Teva Pharmaceutical Industries
AA Pharma
Avadel Pharmaceuticals
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nocturia Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Anticholinergic Drugs
1.2.3 Desmopressin
1.2.4 Antibiotics
1.2.5 Antispasmodic
1.2.6 Others
1.3 Market by Application
1.3.1 Global Nocturia Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Nocturia Market Perspective (2016-2027)
2.2 Nocturia Growth Trends by Regions
2.2.1 Nocturia Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nocturia Historic Market Share by Regions (2016-2021)
2.2.3 Nocturia Forecasted Market Size by Regions (2022-2027)
2.3 Nocturia Industry Dynamic
2.3.1 Nocturia Market Trends
2.3.2 Nocturia Market Drivers
2.3.3 Nocturia Market Challenges
2.3.4 Nocturia Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Nocturia Players by Revenue
3.1.1 Global Top Nocturia Players by Revenue (2016-2021)
3.1.2 Global Nocturia Revenue Market Share by Players (2016-2021)
3.2 Global Nocturia Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nocturia Revenue
3.4 Global Nocturia Market Concentration Ratio
3.4.1 Global Nocturia Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nocturia Revenue in 2020
3.5 Nocturia Key Players Head office and Area Served
3.6 Key Players Nocturia Product Solution and Service
3.7 Date of Enter into Nocturia Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Nocturia Breakdown Data by Type
4.1 Global Nocturia Historic Market Size by Type (2016-2021)
4.2 Global Nocturia Forecasted Market Size by Type (2022-2027)
5 Nocturia Breakdown Data by Application
5.1 Global Nocturia Historic Market Size by Application (2016-2021)
5.2 Global Nocturia Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Nocturia Market Size (2016-2027)
6.2 North America Nocturia Market Size by Type
6.2.1 North America Nocturia Market Size by Type (2016-2021)
6.2.2 North America Nocturia Market Size by Type (2022-2027)
6.2.3 North America Nocturia Market Size by Type (2016-2027)
6.3 North America Nocturia Market Size by Application
6.3.1 North America Nocturia Market Size by Application (2016-2021)
6.3.2 North America Nocturia Market Size by Application (2022-2027)
6.3.3 North America Nocturia Market Size by Application (2016-2027)
6.4 North America Nocturia Market Size by Country
6.4.1 North America Nocturia Market Size by Country (2016-2021)
6.4.2 North America Nocturia Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Nocturia Market Size (2016-2027)
7.2 Europe Nocturia Market Size by Type
7.2.1 Europe Nocturia Market Size by Type (2016-2021)
7.2.2 Europe Nocturia Market Size by Type (2022-2027)
7.2.3 Europe Nocturia Market Size by Type (2016-2027)
7.3 Europe Nocturia Market Size by Application
7.3.1 Europe Nocturia Market Size by Application (2016-2021)
7.3.2 Europe Nocturia Market Size by Application (2022-2027)
7.3.3 Europe Nocturia Market Size by Application (2016-2027)
7.4 Europe Nocturia Market Size by Country
7.4.1 Europe Nocturia Market Size by Country (2016-2021)
7.4.2 Europe Nocturia Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Nocturia Market Size (2016-2027)
8.2 Asia-Pacific Nocturia Market Size by Type
8.2.1 Asia-Pacific Nocturia Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nocturia Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nocturia Market Size by Type (2016-2027)
8.3 Asia-Pacific Nocturia Market Size by Application
8.3.1 Asia-Pacific Nocturia Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nocturia Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nocturia Market Size by Application (2016-2027)
8.4 Asia-Pacific Nocturia Market Size by Region
8.4.1 Asia-Pacific Nocturia Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nocturia Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Nocturia Market Size (2016-2027)
9.2 Latin America Nocturia Market Size by Type
9.2.1 Latin America Nocturia Market Size by Type (2016-2021)
9.2.2 Latin America Nocturia Market Size by Type (2022-2027)
9.2.3 Latin America Nocturia Market Size by Type (2016-2027)
9.3 Latin America Nocturia Market Size by Application
9.3.1 Latin America Nocturia Market Size by Application (2016-2021)
9.3.2 Latin America Nocturia Market Size by Application (2022-2027)
9.3.3 Latin America Nocturia Market Size by Application (2016-2027)
9.4 Latin America Nocturia Market Size by Country
9.4.1 Latin America Nocturia Market Size by Country (2016-2021)
9.4.2 Latin America Nocturia Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Nocturia Market Size (2016-2027)
10.2 Middle East & Africa Nocturia Market Size by Type
10.2.1 Middle East & Africa Nocturia Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nocturia Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nocturia Market Size by Type (2016-2027)
10.3 Middle East & Africa Nocturia Market Size by Application
10.3.1 Middle East & Africa Nocturia Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nocturia Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nocturia Market Size by Application (2016-2027)
10.4 Middle East & Africa Nocturia Market Size by Country
10.4.1 Middle East & Africa Nocturia Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nocturia Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Allergan
11.1.1 Allergan Company Details
11.1.2 Allergan Business Overview
11.1.3 Allergan Nocturia Introduction
11.1.4 Allergan Revenue in Nocturia Business (2016-2021)
11.1.5 Allergan Recent Development
11.2 Urigen Pharmaceuticals
11.2.1 Urigen Pharmaceuticals Company Details
11.2.2 Urigen Pharmaceuticals Business Overview
11.2.3 Urigen Pharmaceuticals Nocturia Introduction
11.2.4 Urigen Pharmaceuticals Revenue in Nocturia Business (2016-2021)
11.2.5 Urigen Pharmaceuticals Recent Development
11.3 Ferring Pharmaceuticals
11.3.1 Ferring Pharmaceuticals Company Details
11.3.2 Ferring Pharmaceuticals Business Overview
11.3.3 Ferring Pharmaceuticals Nocturia Introduction
11.3.4 Ferring Pharmaceuticals Revenue in Nocturia Business (2016-2021)
11.3.5 Ferring Pharmaceuticals Recent Development
11.4 Glenmark Pharmaceuticals
11.4.1 Glenmark Pharmaceuticals Company Details
11.4.2 Glenmark Pharmaceuticals Business Overview
11.4.3 Glenmark Pharmaceuticals Nocturia Introduction
11.4.4 Glenmark Pharmaceuticals Revenue in Nocturia Business (2016-2021)
11.4.5 Glenmark Pharmaceuticals Recent Development
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Details
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Nocturia Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Nocturia Business (2016-2021)
11.5.5 Teva Pharmaceutical Industries Recent Development
11.6 AA Pharma
11.6.1 AA Pharma Company Details
11.6.2 AA Pharma Business Overview
11.6.3 AA Pharma Nocturia Introduction
11.6.4 AA Pharma Revenue in Nocturia Business (2016-2021)
11.6.5 AA Pharma Recent Development
11.7 Avadel Pharmaceuticals
11.7.1 Avadel Pharmaceuticals Company Details
11.7.2 Avadel Pharmaceuticals Business Overview
11.7.3 Avadel Pharmaceuticals Nocturia Introduction
11.7.4 Avadel Pharmaceuticals Revenue in Nocturia Business (2016-2021)
11.7.5 Avadel Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Nocturia Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Anticholinergic Drugs
Table 3. Key Players of Desmopressin
Table 4. Key Players of Antibiotics
Table 5. Key Players of Antispasmodic
Table 6. Key Players of Others
Table 7. Global Nocturia Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Nocturia Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Nocturia Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Nocturia Market Share by Regions (2016-2021)
Table 11. Global Nocturia Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Nocturia Market Share by Regions (2022-2027)
Table 13. Nocturia Market Trends
Table 14. Nocturia Market Drivers
Table 15. Nocturia Market Challenges
Table 16. Nocturia Market Restraints
Table 17. Global Nocturia Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Nocturia Market Share by Players (2016-2021)
Table 19. Global Top Nocturia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturia as of 2020)
Table 20. Ranking of Global Top Nocturia Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Nocturia Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Nocturia Product Solution and Service
Table 24. Date of Enter into Nocturia Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Nocturia Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Nocturia Revenue Market Share by Type (2016-2021)
Table 28. Global Nocturia Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Nocturia Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Nocturia Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Nocturia Revenue Market Share by Application (2016-2021)
Table 32. Global Nocturia Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Nocturia Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Nocturia Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Nocturia Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Nocturia Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Nocturia Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Nocturia Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Nocturia Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Nocturia Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Nocturia Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Nocturia Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Nocturia Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Nocturia Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Nocturia Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nocturia Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nocturia Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nocturia Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Nocturia Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Nocturia Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Nocturia Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Nocturia Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Nocturia Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Nocturia Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Nocturia Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Nocturia Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Nocturia Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nocturia Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nocturia Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nocturia Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Nocturia Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Nocturia Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Nocturia Market Size by Country (2022-2027) & (US$ Million)
Table 64. Allergan Company Details
Table 65. Allergan Business Overview
Table 66. Allergan Nocturia Product
Table 67. Allergan Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 68. Allergan Recent Development
Table 69. Urigen Pharmaceuticals Company Details
Table 70. Urigen Pharmaceuticals Business Overview
Table 71. Urigen Pharmaceuticals Nocturia Product
Table 72. Urigen Pharmaceuticals Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 73. Urigen Pharmaceuticals Recent Development
Table 74. Ferring Pharmaceuticals Company Details
Table 75. Ferring Pharmaceuticals Business Overview
Table 76. Ferring Pharmaceuticals Nocturia Product
Table 77. Ferring Pharmaceuticals Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 78. Ferring Pharmaceuticals Recent Development
Table 79. Glenmark Pharmaceuticals Company Details
Table 80. Glenmark Pharmaceuticals Business Overview
Table 81. Glenmark Pharmaceuticals Nocturia Product
Table 82. Glenmark Pharmaceuticals Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 83. Glenmark Pharmaceuticals Recent Development
Table 84. Teva Pharmaceutical Industries Company Details
Table 85. Teva Pharmaceutical Industries Business Overview
Table 86. Teva Pharmaceutical Industries Nocturia Product
Table 87. Teva Pharmaceutical Industries Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 88. Teva Pharmaceutical Industries Recent Development
Table 89. AA Pharma Company Details
Table 90. AA Pharma Business Overview
Table 91. AA Pharma Nocturia Product
Table 92. AA Pharma Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 93. AA Pharma Recent Development
Table 94. Avadel Pharmaceuticals Company Details
Table 95. Avadel Pharmaceuticals Business Overview
Table 96. Avadel Pharmaceuticals Nocturia Product
Table 97. Avadel Pharmaceuticals Revenue in Nocturia Business (2016-2021) & (US$ Million)
Table 98. Avadel Pharmaceuticals Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nocturia Market Share by Type: 2020 VS 2027
Figure 2. Anticholinergic Drugs Features
Figure 3. Desmopressin Features
Figure 4. Antibiotics Features
Figure 5. Antispasmodic Features
Figure 6. Others Features
Figure 7. Global Nocturia Market Share by Application: 2020 VS 2027
Figure 8. Hospital Pharmacies Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Nocturia Report Years Considered
Figure 12. Global Nocturia Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Nocturia Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Nocturia Market Share by Regions: 2020 VS 2027
Figure 15. Global Nocturia Market Share by Regions (2022-2027)
Figure 16. Global Nocturia Market Share by Players in 2020
Figure 17. Global Top Nocturia Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nocturia as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Nocturia Revenue in 2020
Figure 19. Global Nocturia Revenue Market Share by Type (2016-2021)
Figure 20. Global Nocturia Revenue Market Share by Type (2022-2027)
Figure 21. North America Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Nocturia Market Share by Type (2016-2027)
Figure 23. North America Nocturia Market Share by Application (2016-2027)
Figure 24. North America Nocturia Market Share by Country (2016-2027)
Figure 25. United States Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Nocturia Market Share by Type (2016-2027)
Figure 29. Europe Nocturia Market Share by Application (2016-2027)
Figure 30. Europe Nocturia Market Share by Country (2016-2027)
Figure 31. Germany Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Nocturia Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Nocturia Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Nocturia Market Share by Region (2016-2027)
Figure 41. China Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Nocturia Market Share by Type (2016-2027)
Figure 49. Latin America Nocturia Market Share by Application (2016-2027)
Figure 50. Latin America Nocturia Market Share by Country (2016-2027)
Figure 51. Mexico Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Nocturia Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Nocturia Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Nocturia Market Share by Country (2016-2027)
Figure 57. Turkey Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Nocturia Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Allergan Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 61. Urigen Pharmaceuticals Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 62. Ferring Pharmaceuticals Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 63. Glenmark Pharmaceuticals Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 65. AA Pharma Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 66. Avadel Pharmaceuticals Revenue Growth Rate in Nocturia Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…- 世界の植物・植物由来薬剤市場規模・現状・予測（2021年-2027年） Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi…
- 世界のマイクロバイオーム医薬品市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Microbiome Drugs Market The global Microbiome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integrity, the report makes a b…
- 世界のOTC外用薬市場規模・現状・予測（2021年-2027年） Topical drugs are used for the application where body surfaces such as the skin or mucous membranes to treat ailments. OTC Topical drugs are epicutaneous medication that are applied in the skin directly. The large range of classes included in the topical drugs are creams, foams, gels, lotions and oi…
- 世界の抗酸菌症治療薬市場規模・現状・予測（2021年-2027年） Antimycobacterial drugs are used to treat infections caused by members of Mycobacterium genus. Mycobacterium genus includes M. tuberculosis, M. leprae, and M. avium-intracellulare which cause tuberculosis, leprosy, and atypical mycobacteria, respectively. The hospital pharmacies segment dominated th…